Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00819793 · ClinicalTrials.gov registry record · NA

CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass

A NA study, sponsored by Abbott Medical Devices.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT00819793 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 32 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00819793, a NA study, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

The purpose of the study is to evaluate the safety and effectiveness of the CentriMag ventricular assist system to help patients who have experienced heart failure during surgery and cannot be removed from cardiac bypass.

Interventions

  • DEVICE CentriMag Ventricular Assist System

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2008-10
Est. Completion 2013-09
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

What the Registry Record Tells You About NCT00819793

The ClinicalTrials.gov registry entry for NCT00819793 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which CentriMag Ventricular Assist System is the first listed.

NCT00819793 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00819793 about?

NCT00819793 is a clinical study titled "CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulmonary Bypass". The purpose of the study is to evaluate the safety and effectiveness of the CentriMag ventricular assist system to help patients who have experienced heart failure during surgery and cannot be removed from cardiac bypass.

What is the current status of trial NCT00819793?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2008-10. Estimated completion is 2013-09.

What interventions are being tested in trial NCT00819793?

The interventions under investigation include: CentriMag Ventricular Assist System (DEVICE).

Who is sponsoring clinical trial NCT00819793?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.